Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer

BACKGROUND: Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. METHODS AND FINDINGS: We reviewed 227 AoV Ca patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Hye rim, Oh, Do-Youn, Kim, Tae-Yong, Lee, KyoungBun, Kim, Kyubo, Lee, Kyung-Hun, Han, Sae-Won, Chie, Eui Kyu, Jang, Jin-Young, Im, Seock-Ah, Kim, Tae-You, Kim, Sun-Whe, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790941/
https://www.ncbi.nlm.nih.gov/pubmed/26974670
http://dx.doi.org/10.1371/journal.pone.0151406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790941/
https://www.ncbi.nlm.nih.gov/pubmed/26974670
http://dx.doi.org/10.1371/journal.pone.0151406

Ejemplares similares